Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare Part B Average Sales Prices Will Be Published In December – CMS

This article was originally published in The Pink Sheet Daily

Executive Summary

2005 payment rates, which will be based on third quarter 2004 data supplied by manufacturers, will not be ready in time to be included in CMS's final Physician Fee Schedule rule, which the agency plans to release Nov. 1. The final rule will also include recommended billing code changes.

You may also be interested in...



CMS Expects No Significant Change In Average Sales Prices Before 2005

The agency’s final 2005 Physician Fee Schedule includes a second round of preliminary ASPs, with data for a larger number of drugs than in the proposed rule. Final average sales prices for the first quarter of 2005 will be published in December.

CMS Expects No Significant Change In Average Sales Prices Before 2005

The agency’s final 2005 Physician Fee Schedule includes a second round of preliminary ASPs, with data for a larger number of drugs than in the proposed rule. Final average sales prices for the first quarter of 2005 will be published in December.

CMS To Increase Flu Vaccine Administration Fees In Final Part B Rule

The Center for Medicare & Medicaid Services' final 2005 Physician Fee Schedule is understood to include a payment increase for administration of the flu vaccine to Medicare beneficiaries

Related Content

Topics

UsernamePublicRestriction

Register

PS063835

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel